CO-DIAGNOSTICS, INC. (CODX) Total liabilities 2017–2025
CO-DIAGNOSTICS, INC. (CODX) total liabilities at each fiscal year-end, per SEC filings.
$4.1MFY2025 · since FY2017: $811,802 → $4.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.1M | -57.5% |
| FY2024 | $9.7M | +4.1% |
| FY2023 | $9.3M | +8.6% |
| FY2022 | $8.6M | -66.5% |
| FY2021 | $25.6M | +462.9% |
| FY2020 | $4.5M | +849.8% |
| FY2019 | $478,070 | -81.7% |
| FY2018 | $2.6M | +221.8% |
| FY2017 | $811,802 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CODX financial trends
CODX RevenueCODX Net incomeCODX Net marginCODX Gross profitCODX Gross marginCODX Operating incomeCODX Operating marginCODX Operating cash flowCODX Free cash flowCODX Capital expendituresCODX Return on equityCODX Stock buybacksCODX Dividends paidCODX Total assetsCODX Shareholders’ equityCODX overview →